| #31 |
Ming-Tain Lai |
Merck |
1 |
| #31 |
Jeffrey C. Herbert |
Mentor Graphics |
1 |
| #31 |
Boyoung Kim |
Merck |
1 |
| #31 |
Daniel L. Pitts |
Monsanto Technology |
1 |
| #31 |
Adam Turkelson |
Slyce Acquisition |
1 |
| #31 |
Andrew Hakfan Chen |
Merck |
1 |
| #31 |
Ahmed H. El-Shaer |
Linestream Technologies |
1 |
| #31 |
Laibin Yan |
GE |
1 |
| #31 |
Edward J. Marlinski |
— |
1 |
| #31 |
Anand Mehta |
Drexel University |
1 |
| #31 |
Richard Charles Lawrence |
Trinity Bay Equipment Holdings |
1 |
| #31 |
Changmin Jung |
Rhodia Operations |
1 |
| #31 |
Thomas William Kermis |
Rohm And Haas |
1 |
| #31 |
David Harding |
Cybersoft |
1 |
| #31 |
Allen B. Reitz |
Johnson & Johnson |
1 |
| #31 |
Aimin Tang |
Merck |
1 |
| #31 |
Patrick O'Leary |
Sensormatic Electronics |
1 |
| #31 |
Michael McLane |
Thomson Licensing |
1 |
| #31 |
Colin Valentis |
Rex Medical |
1 |
| #31 |
Anna Slager |
Inovio Pharmaceuticals |
1 |
| #31 |
Wei Qin |
Kulicke And Soffa Industries |
1 |
| #31 |
Feng Dong |
Merck |
1 |
| #31 |
Kristi A. Leonard |
Johnson & Johnson |
1 |
| #31 |
Christopher Ton |
Mesoblast International Sàrl |
1 |
| #31 |
Steve Young |
University of Florida |
1 |
| #31 |
Homayoun Jamasbi |
Rohm And Haas |
1 |
| #31 |
Eileen Fleck Warwick |
Rohm And Haas |
1 |
| #31 |
Gregory Goldmacher |
Merck |
1 |
| #31 |
Rasappa Arumugham |
Pfizer |
1 |
| #31 |
Dennis G. Grubb |
Aquablok |
1 |